NOT-CA-18-101: Notice of NCI Participation in RFA-ES-18-011, Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)

Notice of NCI Participation in RFA-ES-18-011, Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (U2C Clinical Trial Not Allowed)

Notice Number: NOT-CA-18-101

Key Dates
Release Date: August 30, 2018

Related Announcements
RFA-ES-18-011

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) will participate, effective immediately, in RFA-ES-18-011, Human Health Exposure Analysis Resource: Targeted Exposure Analysis Laboratories (UC2 Clinical Trial Not Allowed).

The following changes have been made in RFA-ES-18-011 under each of the headings (below) to reflect NCI's participation in this funding opportunity announcement (FOA

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.399

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Gary Ellison, Ph.D., M.P.H.
National Cancer Institute
Telephone: 240-276-6783
Email: [email protected]

Financial/Grants Management Contact(s)

Crystal Wolfrey
National Cancer Institute
Telephone: 240-276-6277
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Gary Ellison, Ph.D., M.P.H.
National Cancer Institute
Telephone: 240-276-6783
Email: [email protected]